Gyre Therapeutics Inc.

8.08
-0.32 (-3.81%)
At close: Apr 16, 2025, 10:00 AM

Gyre Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
105.76M 113.45M 794K 7.34M 20.95M n/a 6K 1.02M 399K
3.88M 4.64M 798K 7.38M 9.16M 43.86M 21.47M 12.85M 10.55M
101.87M 108.81M -4K -42K 11.79M -43.86M -21.47M -11.83M -10.16M
16.16M -67.23M -8.61M -87.89M -57.37M -57.28M -33.82M -21.82M -20.42M
1.55M n/a 537K 39K 1.13M 2.1M 3.77M 261K 3.47M
23.22M -76.97M -7.89M -87.93M -56.24M -55.18M -30.05M -21.56M -16.95M
12.09M -92.93M 2.3M -87.93M -55.54M -52.89M -30.05M -21.56M -16.95M
73.62M 75.82M 17.37M 18.96M 16.18M 13.42M 12.35M 9.99M 9.26M
12.02M 13.78M 13.04M 68.89M 52.98M 43.86M 21.47M 12.85M 11.55M
66K 86.44M -517K -78K 568K -46K 1.65M 261K 86K
85.71M 176.04M 30.4M 87.85M 69.16M 57.28M 33.83M 22.84M 20.82M
n/a n/a 717K n/a n/a n/a n/a n/a n/a
57.51M 61.16M 54.24M 44.65M n/a n/a n/a n/a n/a
89.59M 180.68M 31.2M 95.23M 78.32M 57.28M 33.83M 22.84M 20.82M
5.32M 8.52M 348K -39K -699K -2.29M 3.77M -173K 3.08M
85.09M 65.83M 76.74M 30.64M 19.18M 12M 11.21M 3.42M 778.78K
102.29M 65.83M 75.69M 30.64M 19.18M 12M 11.21M 3.42M 778.78K
0.14 -1.41 0.04 -2.87 -2.9 -4.41 -2.68 -6.3 -21.76
0.05 -1.41 0.03 -2.87 -2.9 -4.41 -2.68 -6.3 -21.76
16.16M 20.33M 10.33M -87.6M -57.37M -57.28M -33.82M -21.82M -16.95M
16.23M 19.21M 9.2M -87.93M -56.24M -55.18M -30.05M -21.56M -16.95M
-66K 1.11M 1.13M 290K 138K 146K 149K 173K 389K